Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the
Code de commerce
(the French Commercial Code) and article 223-16 of the
Règlement général de l'Autorité des Marchés Financiers
(Regulation of the French stock market authority)
Sanofi
a French
société anonyme
with a registered share capital of 2,519,175,062 €
Registered office : 54, rue La Boétie - 75008 Paris - France
Registered at the Paris Commercial and Companies Registry under number 395 030 844
| Date |
Total number of issued shares |
Number of real voting rights (excluding treasury shares) |
Theoretical number of voting rights (including treasury shares)* |
| May 31, 2017 | 1,260,464,495 | 1,404,784,054 | 1,406,899,520 |
* Pursuant to article 223-11 of the
Règlement général de l'Autorité des Marchés Financiers.
This information is also available on the internet website of sanofi under « Regulated Information in France »:
http://en.sanofi.com/investors/regulated_info_france/regulated_info_france.asp
Investor Relations Department
Europe Tel: + 33 1 53 77 45 45 US Tel: + 1 908 981 5560
e-mail:
IR@sanofi.com
Media Relations Department
Tel: + 33 1 53 77 46 46
e-mail:
MR@sanofi.com
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sanofi via GlobeNewswire